A 2024 study in Cardiovascular Diabetology found that those who retained 6% or more of their pre-pregnancy weight by five years after giving birth face higher risks of pre-diabetes, unhealthy cholesterol levels, and other early markers of heart disease
236 Cardiovascular System During the 1990s, several cell types in the human cardiovascular system were found to express GLP-1R, such as vascular smooth muscle, cardiomyocytes, endocardium, and coronary endothelium/smooth muscle
[3] Challenges in Establishing Optimal GLP-1 Dosing Regimens During the development phase, oral GLP-1 therapies can present particular challenges, however
While the drug is approved for type 2 diabetes management and cardiovascular risk reduction in high-risk patients with diabetes, it contains the same active ingredient (semaglutide) as Wegovy, but costs less than the injection
Pennsylvania restricts weight-loss drugs for Medicaid patients amid budget woes
Cardiac Failure Review